Hypha Labs, Inc. engages in the research, development, and commercialization of a bioreactor. The company is headquartered in Las Vegas, Nevada and currently employs 7 full-time employees. The company went IPO on 2011-12-23. The Hypha Micropearl bioreactor is a home appliance designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company’s device, together with its replacement cartridges, produces enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contain active mushroom ingredients that offer a way to harness the medicinal properties of fungi in a concentrated easy to handle tasteless and odorless form. These Micropearls can be incorporated into various food and beverages without altering the flavor. The QR codes on the cartridges are scanned to the Hypha Lab app and inserted into the device and the Micropearls are produced and fully formed in eight days. Its Hypha Micropearl bioreactor is to be sold with replaceable cartridges.
FUNI stock price ended at $0.04 on 木曜日, after rising 0.00%
On the latest trading day Jan 15, 2026, the stock price of FUNI rose by 0.00%, climbing from $0.04 to $0.04. During the session, the stock saw a volatility of 33.33%, with prices oscillating between a daily low of $0.03 and a high of $0.04. Notably, trading volume dropped by 153.4K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 154.4K shares were traded, equating to a market value of approximately $5.8M.